awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
Graphs
1
Q38931845-CA628F1F-340B-4090-85A3-45EAC8E9CF91
Q38931845-CA628F1F-340B-4090-85A3-45EAC8E9CF91
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38931845-CA628F1F-340B-4090-85A3-45EAC8E9CF91
What Are We Learning from the FDA-Mandated Cardiovascular Outcome Studies for New Pharmacological Antidiabetic Agents?
P2860
Q38931845-CA628F1F-340B-4090-85A3-45EAC8E9CF91
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38931845-CA628F1F-340B-4090-85A3-45EAC8E9CF91
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fb2b9688180b817f1b1cb52073e3974d7b8cb2dd
P2860
Rationale, design, and organization of a randomized, controlled Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) in patients with type 2 diabetes and established cardiovascular disease.